相关实验视频

Updated: Jan 10, 2026

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation

Published on: October 20, 2022

CPX-351与常规化疗在高风险AML中的心脏毒性:一项特例后期III期试验分析

Joshua D Mitchell¹, Michael Pfeiffer², John Boehmer²

¹Washington University School of Medicine, 660 S. Euclid Ave, St Louis, MO, 63110, USA. jdmitchell@wustl.edu.

Cardio-oncology (London, England)

|November 26, 2025

概括

CPX-351是一种针对急性髓性白血病 (AML) 的新型化疗法,与标准7+3治疗相比,其心脏毒性较小. 这一发现增加了CPX-351的数量.

科学领域:

心脏病学心脏病学
血液学血液学血液学
在瘤学瘤学.

背景情况:

CPX-351是一种体组合的诺鲁比和cytarabine,可改善急性髓性白血病 (AML) 的存活率.
与AML患者的标准7+3治疗方案相比,CPX-351的心脏毒性概况尚未明确.

研究的目的:

在高风险AML患者中评估CPX-351与7+3的相对心脏毒性.
通过心声学和不良事件报告来评估心脏功能变化.

主要方法:

对102名AML患者 (57 CPX-351,45 7+3) 的后期分析,他们的左心室喷射分数 (LVEF) 在基线正常.
在基线和随访时对LVEF和左心室全球纵向应变 (GLS) 的心声评估.
对心脏不良事件 (AE) 的评估.

主要成果:

临床上显著的LVEF和GLS下降较少发生在CPX-351和7+3.3之间.
在最后的随访中,没有CPX-351患者出现LVEF<53%,而7+3患者中有17.8%.
心脏AE是相似的,尽管心力衰竭在CPX-351中更常见,心房动/动在7+3.3中更常见.

结论:

与高风险AML的7+3相比,CPX-351可能与心脏毒性降低有关.
这一发现,以及改善的生存率,支持CPX-351在AML治疗中的潜在益处.

关键词:

7+3是什么意思 7+3是什么意思急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.人类循环类药物.在CPX-351中使用.心脏有毒性 - 心脏有毒性喷射分数的喷射分数是什么

更多相关视频

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...